About
Below are the data sources, methods and definitions for the data.
Diagnosed diabetes cases (prevalence)
Level
State
Definition
The number of people aged 18 years or older in the state who reported ever being told by a health professional that they have diabetes.
Methods
Data from the Behavioral Risk Factor Surveillance System (BRFSS) were used to estimate state-level prevalence of diagnosed diabetes among adults (aged 18 years or older). An ongoing, monthly telephone survey of the non-institutionalized adult population in each state, BRFSS provides self-reported, state-specific information on behavioral risk factors for disease and preventive health practices. Respondents were considered to have diagnosed diabetes if they responded “yes” to the question “Has a doctor, nurse, or other health professional ever told you that you have diabetes?” People who indicated that they only had diabetes during pregnancy were not considered to have diabetes.
Data year
2022
Data source
2000-2022 BRFSS, National Center for Chronic Disease Prevention and Health Promotion, CDC.
New diabetes cases (incidence)
Level
State
Definition
The number of adults aged 18 years and older in that state who reported being told by a health professional in the last year that they have diabetes.
Methods
Data from the Behavioral Risk Factor Surveillance System (BRFSS) were used to estimate state-level incidence of diagnosed diabetes among adults (aged 18 years or older). An ongoing, monthly telephone survey of the non-institutionalized adult population in each state, BRFSS provides self-reported, state-specific information on behavioral risk factors for disease and preventive health practices. Respondents were considered to have diagnosed diabetes if they responded “yes” to the question “Has a doctor, nurse, or other health professional ever told you that you have diabetes?” People who indicated that they only had diabetes during pregnancy were not considered to have diabetes. Adults who reported having diagnosed diabetes were asked at what age they were diagnosed. The number of years each person had been diagnosed with diabetes was calculated by subtracting the age at which they were diagnosed from their current age. Adults who had a value of 0 were identified as having been diagnosed with diabetes within the last year. In addition, half of the adults who had a value of 1 were classified as having been diagnosed with diabetes within the last year.
Data years
2020-2022
Data source
2000-2022 BRFSS, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Prediabetes prevalence
Level
State
Definition
The number of adults aged 18 years or older in that state who reported ever being told by a health professional that they had prediabetes.
Methods
Data from the Behavioral Risk Factor Surveillance System (BRFSS) were used to estimate the number of adults (aged 18 years or older) that had ever been notified by a health professional that they had prediabetes, at the state-level. An ongoing, monthly telephone survey of the non-institutionalized adult population in each state, BRFSS provides self-reported, state-specific information on behavioral risk factors for disease and preventive health practices. Results include “Yes” responses to the question “Have you ever been told by a doctor or other health professional that you have prediabetes or borderline diabetes?” and “No, prediabetes or borderline diabetes” responses to the question, “Have you ever been told by a doctor, nurse, or other health professional that you have diabetes?” Responses from people who indicated that they only had prediabetes during pregnancy were not included.
Data years
2017-2022
Data source
2017–20202 BRFSS, National Center for Chronic Disease Prevention and Health Promotion, CDC.
State population
Level
All-states total
State
Definition
The resident population includes all people currently residing in the United States.
The resident population includes all individuals who reside in each state and the District of Columbia.
Methods
The population estimate at any given time point starts with a population base (e.g., the last decennial census or the previous point in the time series), adds births, subtracts deaths, and adds net migration (both international and domestic). The individual methods used to account for additional factors such as input data availability and the requirement that all estimates be consistent by geography and age, sex, race, and Hispanic origin.
The population estimate at any given time point starts with a population base (e.g., the last decennial census or the previous point in the time series), adds births, subtracts deaths, and adds net migration (both international and domestic). The individual methods used to account for additional factors such as input data availability and the requirement that all estimates be consistent by geography and age, sex, race, and Hispanic origin.
Data year(s)
April 2020-July 2022
April 2020-July 2022
Data source
Data published by U.S. Census Bureau. https://www.census.gov/newsroom/press-kits/2022/2022-national-state-population-estimates.html.
Data published by U.S. Census Bureau. https://www.census.gov/newsroom/press-kits/2022/2022-national-state-population-estimates.html.
Total medical cost
Level
All-states total
State
Definition
Direct costs are health expenditures associated with treating diabetes and its complications and comorbidities.
Direct medical costs are health expenditures associated with treating diabetes and its complications and comorbidities.
Methods
Data were calculated by combining the total direct medical cost for all 50 states and the District of Colombia.
The data were calculated using an attributable fraction approach to estimate the estimate the diabetes-attributable state health expenditures by age, sex, payer, and service type. This approach used data from several different sources including: 2021 Behavioral Risk Factor Surveillance, 2015–2019 Medical Expenditure Panel Survey, 2021 State Health Expenditure Accounts (SHEA), Centers for Medicare and Medicaid Services Resource Utilization Group payments, CMS 2018–2019 Minimum Data Set, and Nursing Care Facilities and Continuing Care Communities Costs from SHEA. This calculation has also adjusted been for inflation.
AF = (pdj × [RRj1])/(1 pdj × [RRj 1]), where pd represents the diabetes prevalence, RR represents the ratio of medical costs for individuals with and without diabetes, and j indicates age, sex, payer, and service type.
Data year
2022
2022
Data source
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Total Medicare cost
Level
All-states total
State
Definition
Medicare medical costs are health expenditures associated with treating diabetes and its complications.
Medicare medical costs are health expenditures associated with treating diabetes and its complications.
Methods
Data were calculated by combining the total Medicare cost for all 50 states and the District of Colombia.
The data were calculated using an attributable fraction approach to estimate the estimate the diabetes attributable state health expenditures by age, sex, payer, and service type. This approach used data from several different sources including: 2021 Behavioral Risk Factor Surveillance, 2015–2019 Medical Expenditure Panel Survey, 2021 State Health Expenditure Accounts (SHEA), Centers for Medicare and Medicaid Services Resource Utilization Group payments, CMS 2018–2019 Minimum Data Set, and Nursing Care Facilities and Continuing Care Communities Costs from SHEA. Cost calculated using the number of beneficiaries with diabetes covered by Medicare. This calculation has also adjusted been for inflation.
AF = (pdj × [RRj-1])/(1 +pdj × [RRj -1]), where pd represents the diabetes prevalence, RR represents the ratio of medical costs for individuals with and without diabetes, and j indicates age, sex, payer, and service type.
Data year
2022
2022
Data source
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Total Medicaid cost
Level
All-states total
State
Definition
Medicaid medical costs are health expenditures associated with treating diabetes and its complications.
Medicaid medical costs are health expenditures associated with treating diabetes and its complications.
Methods
Data were calculated by combining the total Medicaid cost for all states and District of Colombia.
The data were calculated using an attributable fraction approach to estimate the estimate the diabetes attributable state health expenditures by age, sex, payer, and service type. This approach used data from several different sources including: 2021 Behavioral Risk Factor Surveillance, 2015–2019 Medical Expenditure Panel Survey, 2021 State Health Expenditure Accounts (SHEA), Centers for Medicare and Medicaid Services Resource Utilization Group payments, CMS 2018–2019 Minimum Data Set, and Nursing Care Facilities and Continuing Care Communities from SHEA. Cost calculated using the number of beneficiaries with diabetes covered by Medicare. This calculation has also adjusted been for inflation.
AF = (pdj × [RRj-1])/(1 +pdj × [RRj -1]), where pd represents the diabetes prevalence, RR represents the ratio of medical costs for individuals with and without diabetes, and j indicates age, sex, payer, and service type.
Data year
2022
2022
Data source
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Diabetes action plan
Level
All-states total
State
Definition
N/A
A report developed by state public health agencies that assesses the status of and outlines plans to address the burden of diabetes in the state.
Methods
Total number of states with a Diabetes Action Plan.
Legislation for state diabetes action plans was identified by searching the Westlaw legal database for statutes that mandate a diabetes action plan. A search engine query was conducted to locate written plans for each state, including plans for states that did not have legislation for a diabetes action plan. Results with a publicly available report on the state health agency website as of October 1, 2024, were accepted as diabetes action plans for this analysis.
Data year
2011-2024
2011-2024
Data source
N/A
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Total DDT investment (funding)
Level
All-states total
State
Definition
Total fiscal year (FY) national funding received from CDC’s Division of Diabetes Translation (DDT).
Total fiscal year (FY) state-level funding received from CDC’s Division of Diabetes Translation (DDT).
Methods
Data were calculated by combining the total funding amounts for all 50 states and the District of Colombia.
The grants and cooperative agreements data in this report include funding obligated and awarded (i.e., obligated funds) domestically to States, the District of Columbia (DC), U.S. Territories and Freely Associated States in fiscal year 2023 (FY23; 10/1/22 to 9/30/23) from CDC’s domestic Appropriations.
Data year
Budget period: October 1,2022—September 30, 2023
Budget period: October 1,2022—September 30, 2023
Data source
Grant Funding, CDC. For more information visit, https://fundingprofiles.cdc.gov/#summaryReports
Grant Funding, CDC. For more information visit, https://fundingprofiles.cdc.gov/#summaryReports
DP 23-0020 investment (funding)
Level
All-states total
State
Definition
Diabetes funding received among all recipients through A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes (DP23-0020) cooperative agreement in Year 1. This 5-year cooperative agreement, which began in October, funds all 50 states and Washington, DC to t prevent or delay onset of type 2 diabetes among adults with prediabetes.
Diabetes funding received among all recipients through A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes (DP23-0020) cooperative agreement in Year 1. This 5-year cooperative agreement, which began in October, funds all 50 states and Washington, DC to t prevent or delay onset of type 2 diabetes among adults with prediabetes.
Methods
Data were calculated by combining the annual DP23-1815 diabetes funding amounts for all 50 states and the District of Colombia.
Data provided by the Division of Diabetes Translation, CDC.
Data year
Budget period: October 1,2022—September 30, 2023
Budget period: October 1,2022—September 30, 2023
Data source
Division of Diabetes Translation, CDC. For more information, visit https://www.cdc.gov/diabetes-state-local/php/funding/cdc-rfa-dp-23-0020-recipients.html
Division of Diabetes Translation, CDC. For more information, visit https://www.cdc.gov/diabetes-state-local/php/funding/cdc-rfa-dp-23-0020-recipients.html
DSMES metrics
Metric
Number of recognized/accredited DSMES service providers* [Column M]
Number of people with diabetes with at least 1 encounter at a recognized/accredited DSMES service* [Column N]
Level
State
State
Definition
Organizations with American Diabetes Association (ADA) recognition or Association of Diabetes Care & Education Specialists (ADCES) accreditation for DSMES services.
People with diabetes that have had at least one DSMES encounter with an organization that is ADA-recognized or ADCES-accredited.
Data year
2022
2022
Data source
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. Unpublished data.
Note: *For the National Diabetes Profile, the totals were calculated by adding together the state numbers.
National DPP Metrics
| Metric | Number of CDC-recognized organizations offering the lifestyle change program* [Column Q] | Number of Medicare Diabetes Prevention Program suppliers* [Column R] | Number of participants enrolled in the National DPP lifestyle change program (LCP)* [Column P] | State Medicaid coverage of the National DPP LCP* [Column S] |
| Level | State | State | State | State |
| Definition | Delivery organizations with CDC recognition by state, based on the physical location of the organization | Delivery organizations offering the Medicare Diabetes Prevention Program by state, based on the physical location of the organization. | Cumulative enrolled participants in the National DPP LCP that report the state as their state of residence. | Includes any level of Medicaid coverage for the National DPP LCP through existing Medicaid state plans or state plan amendments, Medicaid waivers, state Medicaid agency decisions, Medicaid managed care organization (MCO) contract language, voluntary MCO offerings, or pilot projects under way to make the case for coverage. |
| Methods | Since March 2014, the Diabetes Prevention Recognition Program (DPRP) has generated a quarterly DPRP State Report for use by state health department recipients funded by CDC to scale and sustain the National Diabetes Prevention Program (National DPP). CDC’s current recipients are funded through the CDC-RFA-DP-23-0020 cooperative agreement: A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes (2320). | State Medicaid coverage for the National DPP LCP is reported in the National DPP Coverage Toolkit at coveragetoolkit.org. | ||
| Data year | 2023 | 2023 | 2023 | 2024 |
| Data source | Division of Diabetes Translation, CDC. Diabetes Prevention Recognition Program Quarterly State-Level Evaluation Report. January 2023. | Data provided by the Division of Diabetes Translation, CDC. Calculations performed by CDC. | ||
Note: *For the National Diabetes Profile, the totals were calculated by adding together the state numbers.